Product Safety Recalls

Product Recall Tracker

CLONIDINE Recall D-1152-2022

Description: Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufactured for: Mayne Pharma Greenville, NC 27834

CLONIDINE Recall D-1152-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-1152-2022
Event ID90406
BrandCLONIDINE
Generic NameCLONIDINE
ManufacturerCLONIDINE
Original Package?1
Active SubstanceCLONIDINE
Drug RouteTRANSDERMAL
DistributionNationwide in the US Market
Quantity1440 cartons
Recall ReasonDefective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
Drug ClassificationClass II
Drug Code Info20220629
Product NDC51862-453 51862-454 51862-455
Product NUIN0000009918 N0000175554
Pharma Class (EPC)Central alpha-2 Adrenergic Agonist [EPC]
Recall Initiation Date20220609
Report Date20220629
Classification Date20220621
Address1240 Sugg Pkwy
Greenville, NC 27834-9006
United States
Recalling FirmMayne Pharma Inc
Initial Notification Letter
Unique Ingredient IdentifierMN3L5RMN02
Drug Application NumberANDA079090
Structured Product Labeling (SPL ID)d876b634-0405-4ace-b85d-27191bb0b1fc
Structured Product Labeling (SPL Set ID)c41eb913-5e47-46c4-9d96-9a67f8380919
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.